EDGAR·FLOW

Acurx Pharmaceuticals, Inc. — Form 8-K

Filed November 20, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 8/100
What the filing says
Acurx Pharmaceuticals filed an 8-K on 2026-11-20 reporting an event as of 2026-11-18. The filing contains only Item 8.01 (Other Events) with no specific counterparties, dollar amounts, percentages, share counts, or material transaction details disclosed in the header or accessible metadata. The actual event substance is not provided in the document excerpt.
Why this rating

No material transaction, deal, or business change is disclosed. Item 8.01 is catch-all category for miscellaneous events lacking specificity. Without content details, cannot assess impact on $13.7M-cap company.

Extracted items
View original filing on SEC.gov ↗ ACXP · stock on Yahoo Finance ↗

See more from November 20, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.